Trial Condition(s):

Hyperkinetic Syndrome

Effects of Lisuride and placebo in hyperkinetic children

Bayer Identifier:

Trial_EXC009

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

June1975

July1976

Phase

Could I receive a placebo?

Products

Dopergin (Lisuride Hydrogen-Maleate, BAYR5936)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status

Hyperkinetic Syndrome

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

7 Years

15 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information